4.7 Article

Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study

Journal

CLINICAL INFECTIOUS DISEASES
Volume 69, Issue 8, Pages 1278-1287

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciy1105

Keywords

multidrug-resistant TB; prevalence; predictors; treatment outcomes; eastern DR Congo

Funding

  1. Global Affairs Canada
  2. Ghent University
  3. Katholieke Universiteit Leuven in Belgium
  4. University of Antwerp
  5. Universite Catholique de Bukavu in the DRC
  6. Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS) Institutional University Cooperation (IUC) [PRDC 2012MP80]
  7. IUC

Ask authors/readers for more resources

Background. Multidrug-resistant tuberculosis (MDR-TB) jeopardizes global TB control. The prevalence and predictors of Rifampicin-resistant (RR) TB, a proxy for MDR-TB, and the treatment outcomes with standard and shortened regimens have not been assessed in post-conflict regions, such as the South Kivu province in the eastern Democratic Republic of the Congo (DRC). We aimed to fill this knowledge gap and to inform the DRC National TB Program. Methods. A retrospective cohort study of adults and children evaluated for pulmonary TB by sputum smear microscopy and Xpert MTB/RIF (Xpert) from February 2012 to June 2017. Multivariable logistic regression, Kaplan-Meier estimates, and multivariable Cox regression were used to assess independent predictors of RR-TB and treatment failure/death. Results. Of 1535 patients Xpert-positive for TB, 11% had RR-TB. Independent predictors of RR-TB were a positive sputum smear (adjusted odds ratio [aOR] 2.42, 95% confidence interval [CI] 1.63-3.59), retreatment of TB (aOR 4.92, 95% CI 2.31-10.45), and one or more prior TB episodes (aOR 1.77 per episode, 95% CI 1.01-3.10). Over 45% of RR-TB patients had no prior TB history or treatment. The median time from Xpert diagnosis to RR-TB treatment initiation was 12 days (interquartile range 3-60.2). Cures were achieved in 30/36 (83%) and 84/114 (74%) of patients on 9- vs 20/24-month MDR-TB regimens, respectively (P =.06). Predictors of treatment failure/death were the absence of directly observed therapy (DOT; adjusted hazard ratio [aHR] 2.77, 95% CI 1.2-6.66) and any serious adverse drug event (aHR 4.28, 95% CI 1.88-9.71). Conclusions. Favorable RR-TB cure rates are achievable in this post-conflict setting with a high RR-TB prevalence. An expanded Xpert scale-up; the prompt initiation of shorter, safer, highly effective MDR-TB regimens; and treatment adherence support are critically needed to optimize outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory

Samantha Pillay, Margaretha de Vos, Brigitta Derendinger, Elizabeth Maria Streicher, Tania Dolby, Leere Ann Scott, Amy Debra Steinhobel, Rob Mark Warren, Grant Theron

Summary: The MTBDRsl assay fails to generate a result in almost half of smear-negatives, resulting in substantial missed resistance, but has high rule-in value. The study found that MTBDRsl has high sensitivity for fluoroquinolones and second-line injectable drugs, but low specificity for both.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults

Claire J. Calderwood, Byron W. P. Reeve, Tiffeney Mann, Zaida Palmer, Georgina Nyawo, Hridesh Mishra, Gcobisa Ndlangalavu, Ibrahim Abubakar, Mahdad Noursadeghi, Grant Theron, Rishi K. Gupta

Summary: This study assessed the diagnostic accuracy and clinical utility of C-reactive protein (CRP) as a triage test for pulmonary TB among symptomatic adult outpatients. The results showed that CRP had moderate diagnostic accuracy and demonstrated clinical utility.

JOURNAL OF INFECTION (2023)

Article Respiratory System

More than Mycobacterium tuberculosis: site-of-disease microbial communities, and their functional and clinical profiles in tuberculous lymphadenitis

Georgina R. Nyawo, Charissa C. Naidoo, Benjamin Wu, Imran Sulaiman, Jose C. Clemente, Yonghua Li, Stephanie Minnies, Byron W. P. Reeve, Suventha Moodley, Cornelia Rautenbach, Colleen Wright, Shivani Singh, Andrew Whitelaw, Pawel Schubert, Robin Warren, Leopoldo Segal, Grant Theron

Summary: This study investigated the lymph node microbiome in tuberculosis lymphadenitis (TBL) patients and found that the microbiome in TBL lymph nodes is diverse. Different microbial communities are associated with different clinical features and immunomodulatory potentials. These findings lay the groundwork for studying the role of the microbiome in lymphatic TB.

THORAX (2023)

Review Immunology

Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses

Patrick D. M. C. Katoto, Mireille A. M. Kakubu, Jacques L. L. Tamuzi, Amanda S. S. Brand, Adaeze Ayuk, Liliane N. N. Byamungu, Charles S. S. Wiysonge, Glenda Gray

Summary: This study aimed to evaluate the safety and effectiveness of the BNT162b2 vaccine in immunocompromised adolescents and young adults through a meta-analysis of post-marketing studies. The results showed that the BNT162b2 vaccine is safe and effective in immunocompromised individuals, although the evidence quality is low to moderate due to bias risk.

EXPERT REVIEW OF VACCINES (2023)

Article Multidisciplinary Sciences

Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13

Sri Gowtham Thakku, Jackson Lirette, Kanagavel Murugesan, Julie Chen, Grant Theron, Niaz Banaei, Paul C. Blainey, James Gomez, Sharon Y. Wong, Deborah T. Hung

Summary: This study presents a new method called WATSON that can detect microbial cell-free DNA (cfDNA) for diagnosing infection. WATSON utilizes pooled amplification and CRISPR/Cas13-based detection to improve the detection of cfDNA compared to traditional methods. This approach shows potential for point-of-care diagnostic tests for infectious diseases.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

HIV status and survival of patients with pulmonary hypertension due to left heart disease: the Pan African Pulmonary Hypertension Cohort

Patrick D. M. C. Katoto, Sandra L. Mukasa, Mahmoud U. Sani, Kamilu M. Karaye, Irina Mbanze, Albertino Damasceno, Ana O. Mocumbi, Anastase Dzudie, Karen Sliwa, Friedrich Thienemann

Summary: The study examined factors associated with increased right ventricular systolic pressure (RVSP) and the effect of HIV status on survival rate in patients with pulmonary hypertension due to left heart disease (PH-LHD) in sub-Saharan Africa. Exposure to biomass fuel smoke, moderate to severe NYHA/FC, and unknown HIV status predicted increased RVSP at the time of presentation. HIV infection, NYHA/FC, and alcohol consumption were associated with decreased survival probabilities after 6 months. The study also found that an incremental rise in RVSP and inter-ventricular septal thickness resulted in an increased probability of mortality due to PH-LHD, while an increase in BMI reduced the risk of death.

SCIENTIFIC REPORTS (2023)

Editorial Material Biotechnology & Applied Microbiology

Integrating civil liberty and the ethical principle of autonomy in building public confidence to reduce COVID-19 vaccination inequity in Africa

Marilyn A. Couch, Patrick D. M. C. Katoto, Samuel Fikiri Cinini, Charles S. Wiysonge

Summary: Concerns about COVID-19 vaccination safety have led to hesitancy and decreased uptake worldwide. Vaccine hesitancy varies across continents, countries, ethnic groups, and age groups, resulting in global inequities. Africa has the lowest COVID-19 coverage globally, with only 22% of its population fully vaccinated. Misinformation on social media, especially regarding depopulating Africa, may have contributed to vaccine acceptance challenges in the region. This study explores determinants of low vaccination coverage that have received limited attention in primary research and highlights the importance of a multidisciplinary approach to ensure trust and convince individuals of the benefits of vaccination.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Review Biotechnology & Applied Microbiology

Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis

Patrick DMC. Katoto, Jacques L. Tamuzi, Amanda S. Brand, Diana M. Marangu, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray

Summary: This study investigates the effectiveness of the BNT162b2 vaccine in adolescents against symptomatic and severe COVID-19 diseases, the impact of COVID-19 variants on vaccine effectiveness, and the effect of age and time on vaccine effectiveness.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Article Immunology

Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis

Muki Shehu Shey, Avuyonke Balfour, Nomawethu Masina, Abulele Bekiswa, Charlotte Schutz, Rene Goliath, Rachel Dielle, Patrick DMC. Katoto, Katalin Andrea Wilkinson, David Lewinsohn, Deborah Anne Lewinsohn, Graeme Meintjes

Summary: In this study, it was found that individuals who showed resistance to Mycobacterium tuberculosis (Mtb) infection despite sustained exposure had lower secretion of IFN-gamma, a cytokine traditionally associated with Mtb infection. However, these individuals showed similar secretion levels of other immune response-related cytokines and chemokines, indicating their ability to mount non-IFN-gamma immune responses to Mtb infection.

FRONTIERS IN IMMUNOLOGY (2023)

Review Immunology

Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination

Patrick D. M. C. Katoto, Liliane N. Byamungu, Amanda S. Brand, Jacques L. Tamuzi, Mireille A. M. Kakubu, Charles S. Wiysonge, Glenda Gray

Summary: Myocarditis and pericarditis occur at a low rate in adolescents after receiving the BNT162b2 COVID-19 vaccine, with a higher risk after the second dose in males. National programs are advised to use a causality framework to reduce overreporting and extend the inter-dose interval policy to decrease the occurrence of myocarditis/pericarditis.

NPJ VACCINES (2023)

Review Respiratory System

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis

Ashar Dhana, Rishi K. Gupta, Yohhei Hamada, Andre P. Kengne, Andrew D. Kerkhoff, Christina Yoon, Adithya Cattamanchi, Byron W. P. Reeve, Grant Theron, Gcobisa Ndlangalavu, Robin Wood, Paul K. Drain, Claire J. Calderwood, Mahdad Noursadeghi, Tom Boyles, Graeme Meintjes, Gary Maartens, David A. Barr

Summary: This study compared the performance of WHO-recommended tuberculosis screening tools with two newly developed clinical prediction models (CPMs) among outpatient people living with HIV. The results showed that C-reactive protein (CRP) performed the best as a screening tool, and the choice between using CRP or a CPM depends on available resources.

EUROPEAN RESPIRATORY REVIEW (2023)

Article Microbiology

An Archetypical Model for Engrafting Bacteroides fragilis into Conventional Mice Following Reproducible Antibiotic Conditioning of the Gut Microbiota

Osagie A. Eribo, Charissa C. Naidoo, Grant Theron, Gerhard Walzl, Nelita du Plessis, Novel N. Chegou

Summary: This study aimed to develop a reproducible antibiotic-based model for manipulating the gut microbiota and engrafting B. fragilis into mice. Different combinations of antibiotics were evaluated for their efficacy in depleting the Bacteroides population, and a model involving metronidazole/clindamycin treatment followed by B. fragilis transplantation was found to consistently eliminate Bacteroides and facilitate B. fragilis engraftment. This model has potential use in investigating the role of Bacteroides in specific diseases.

MICROORGANISMS (2023)

Article Medicine, General & Internal

Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report

Mireille A. M. Kakubu, Tarisai Bikinesi, Patrick D. M. C. Katoto

Summary: Adverse effects of antiretroviral therapy (ART) can lead to poor adherence and HIV drug resistance mutations, negatively impacting the immune system. Anemia in HIV infection can have multiple causes, including direct effects of the virus on the bone marrow and opportunistic infections. ART drugs can also cause anemia. We report a case of persistent anemia, kidney injury, and treatment failure due to non-adherence to ART. The anemia was classified as Pure Red Cell Aplasia (PRCA) and resolved after treatment modification and withdrawal of lamivudine (3TC).

OXFORD MEDICAL CASE REPORTS (2023)

Article Microbiology

To Test or Not? Xpert MTB/RIF as an Alternative to Smear Microscopy to Guide Line Probe Assay Testing for Drug-Resistant Tuberculosis

S. Pillay, M. de Vos, H. Sohn, Y. Ghebrekristos, T. Dolby, R. M. Warren, G. Theron

Summary: Xpert MTB/RIF (Xpert) revolutionized TB diagnosis and its quantitative information can identify a subset of smear-negative specimens, allowing laboratories to perform drug susceptibility testing on them.

JOURNAL OF CLINICAL MICROBIOLOGY (2023)

Article Public, Environmental & Occupational Health

Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data

Tobias Broger, Lisa Koeppel, Helena Huerga, Poppy Miller, Ankur Gupta-Wright, Francois-Xavier Blanc, Aliasgar Esmail, Byron W. P. Reeve, Marco Floridia, Andrew D Kerkhoff, Fausto Ciccacci, Margaret P. Kasaro, Swe Swe Thit, Mathieu Bastard, Gabriella Ferlazzo, Christina Yoon, DanielJ Van Hoving, Bianca Sossen, Juan Ignacio Garcia, Matthew J. Cummings, Rachel M. Wake, Josh Hanson, Adithya Cattamanchi, Graeme Meintjes, Gary Maartens, Robin Wood, Grant Theron, Keertan Dheda, Ioana Diana Olaru, Claudia M. Denkinger

Summary: This systematic review and meta-analysis compared the diagnostic yield of urine-based tests with sputum-based tests for tuberculosis. The study found that urine-based lipoarabinomannan tests had a higher diagnostic yield than sputum-based nucleic acid amplification tests and sputum smear microscopy. Urine samples are readily available and are particularly important for HIV patients who cannot produce sputum.

LANCET GLOBAL HEALTH (2023)

No Data Available